Acadia Pharmaceuticals: Oppenheimer maintains Perform, raises PT to $23 from $21.

viernes, 6 de febrero de 2026, 12:32 pm ET1 min de lectura
ACAD--

Acadia Pharmaceuticals: Oppenheimer maintains Perform, raises PT to $23 from $21.

Acadia Pharmaceuticals: Oppenheimer maintains Perform, raises PT to $23 from $21.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios